Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis

Anti-angiogenesis targeting VEGFR2 has been an attractive strategy for cancer therapy for its role in promoting cancer growth and metastasis. However, the currently available drugs have unexpected side effects. Therefore, development of novel VEGFR2 inhibitors with less toxicity would be of great va...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tao, Liu, Xiaoxia, Shen, Qin, Yang, Wenjun, Huo, Zhenghao, Liu, Qilun, Jiao, Haiyan, Chen, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042000/
https://www.ncbi.nlm.nih.gov/pubmed/27058891
http://dx.doi.org/10.18632/oncotarget.8555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042000/
https://www.ncbi.nlm.nih.gov/pubmed/27058891
http://dx.doi.org/10.18632/oncotarget.8555

Ejemplares similares